tiprankstipranks
Trending News
More News >
Kuros Biosciences Ltd. (CH:KURN)
:KURN
Switzerland Market
Advertisement

Kuros Biosciences (KURN) Stock Forecast & Price Target

Compare
1 Followers
See the Price Targets and Ratings of:

KURN Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Kuros
Biosciences
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KURN Stock 12 Month Forecast

Average Price Target

CHF32.52
▲(13.79%Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Kuros Biosciences in the last 3 months. The average price target is CHF32.52 with a high forecast of CHF32.52 and a low forecast of CHF32.52. The average price target represents a 13.79% change from the last price of CHF28.58.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"11":"CHF11","22":"CHF22","33":"CHF33","16.5":"CHF16.5","27.5":"CHF27.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":32.51953669578607,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF32.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.5205339012,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF32.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.51953669578607,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF32.52</span>\n  </div></div>","useHTML":true}}],"tickPositions":[11,16.5,22,27.5,33],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.88,26.390733591983544,26.90146718396709,27.41220077595063,27.922934367934175,28.43366795991772,28.944401551901265,29.45513514388481,29.96586873586835,30.476602327851896,30.98733591983544,31.498069511818983,32.00880310380253,{"y":32.51953669578607,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.88,26.390810300092305,26.901620600184614,27.41243090027692,27.92324120036923,28.434051500461536,28.944861800553845,29.45567210064615,29.96648240073846,30.477292700830766,30.988103000923076,31.49891330101538,32.00972360110769,{"y":32.5205339012,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,25.88,26.390733591983544,26.90146718396709,27.41220077595063,27.922934367934175,28.43366795991772,28.944401551901265,29.45513514388481,29.96586873586835,30.476602327851896,30.98733591983544,31.498069511818983,32.00880310380253,{"y":32.51953669578607,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.22,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":13.26,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.9,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.86,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.85,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":21.35,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.95,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.1,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.38,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.72,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.88,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.88,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF32.52Average Price TargetCHF32.52Lowest Price TargetCHF32.52
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:KURN
TipRanks AITipRanks
Not Ranked
TipRanks
CHF30
Hold
4.97%
Upside
Reiterated
06/27/25
Kuros Biosciences' strengths lie in its strong revenue growth and improving cash flows, supported by a solid balance sheet. However, the lack of profitability and high P/E ratio are significant concerns impacting the valuation score. Technical analysis suggests bullish momentum, which supports a moderately favorable outlook.
Kepler Capital  Analyst forecast on CH:KURN
Christophe dombuKepler Capital
Kepler Capital
CHF32.5
Buy
13.72%
Upside
Reiterated
06/16/25
Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (Other OTC: CSBTF), CSL (Other OTC: CMXHF) and Roche Holding AG (Other OTC: RHHVF)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CH:KURN
TipRanks AITipRanks
Not Ranked
TipRanks
CHF30
Hold
4.97%
Upside
Reiterated
06/27/25
Kuros Biosciences' strengths lie in its strong revenue growth and improving cash flows, supported by a solid balance sheet. However, the lack of profitability and high P/E ratio are significant concerns impacting the valuation score. Technical analysis suggests bullish momentum, which supports a moderately favorable outlook.
Kepler Capital  Analyst forecast on CH:KURN
Christophe dombuKepler Capital
Kepler Capital
CHF32.5
Buy
13.72%
Upside
Reiterated
06/16/25
Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (Other OTC: CSBTF), CSL (Other OTC: CMXHF) and Roche Holding AG (Other OTC: RHHVF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kuros Biosciences

1 Month
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+11.10%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +11.10% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+12.60%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +12.60% per trade.
1 Year
Christophe dombuKepler Capital
Success Rate
1/1 ratings generated profit
100%
Average Return
+12.60%
reiterated a buy rating last month
Copying Christophe dombu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +12.60% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+12.60%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +12.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KURN Analyst Recommendation Trends

Rating
Jun 25
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
total
3
In the current month, KURN has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. KURN average Analyst price target in the past 3 months is 32.52.
Each month's total comprises the sum of three months' worth of ratings.

KURN Financial Forecast

KURN Earnings Forecast

The previous quarter’s earnings for KURN were -CHF0.11.
The previous quarter’s earnings for KURN were -CHF0.11.

KURN Sales Forecast

Next quarter’s sales forecast for KURN is CHF27.90M with a range of CHF27.90M to CHF27.90M. The previous quarter’s sales results were CHF43.71M. KURN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year KURN has Outperformed its overall industry.
Next quarter’s sales forecast for KURN is CHF27.90M with a range of CHF27.90M to CHF27.90M. The previous quarter’s sales results were CHF43.71M. KURN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year KURN has Outperformed its overall industry.

KURN Stock Forecast FAQ

What is CH:KURN’s average 12-month price target, according to analysts?
Based on analyst ratings, Kuros Biosciences Ltd.’s 12-month average price target is 32.52.
    What is CH:KURN’s upside potential, based on the analysts’ average price target?
    Kuros Biosciences Ltd. has 13.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Kuros Biosciences Ltd. a Buy, Sell or Hold?
          Kuros Biosciences Ltd. has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Kuros Biosciences Ltd.’s share price target?
            The average share price target for Kuros Biosciences Ltd. is 32.52. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF32.52 ,and the lowest forecast is CHF32.52. The average share price target represents 13.79% Increase from the current price of CHF28.58.
              What do analysts say about Kuros Biosciences Ltd.?
              Kuros Biosciences Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Kuros Biosciences Ltd.?
                To buy shares of CH:KURN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis